Key facts
- It has raised $2.1B; the latest was Debt Refinancing ($265.0M) in May 2025.
- Notable investors include The Carlyle Group, Patient Square Capital, Cannae Holdings, Sanaka Capital, TripleTree — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for CorroHealth
- ·The full record, as it builds
Funding rounds
No funding rounds for CorroHealth are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About CorroHealth
Provider of reimbursement cycle tracking services to the healthcare industry. The company navigates regulatory and compliance complexities, integration and revenue cycle technology, eases physician burdens and improves financial outcomes, helping the payers improve financial outcomes.
- Sector
- Information Technology
- HQ
- Plano, TX, United States
- Founded
- 2020
- Employees
- 17,000
- Website
- corrohealth.com/
- Ownership
- Privately Held (backing)
CorroHealth doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CorroHealth shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CorroHealth in its N-PORT filings yet. We sweep new filings monthly.